![](/img/cover-not-exists.png)
Efficacy and safety of an anti-CD20monoclonal antibody (Reditux™) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs
Bhati, Manjeet, Bandyopadhyay, SyamasisVolume:
35
Language:
english
Journal:
Clinical Rheumatology
DOI:
10.1007/s10067-016-3332-8
Date:
August, 2016
File:
PDF, 275 KB
english, 2016